Tuberculosis Aerobiology – Antonio Rothfuchs group

We use air sampling to study the survival and infectiousness of M. tuberculosis in aerosols, and to detect M. tuberculosis in cough and indoor air.

Lab picture Tony Rotfuchs

Research focus

Survival and infectiousness of Mycobacterium tuberculosis after aerosolization

Tuberculosis (TB) is transmitted when aerosols carrying Mycobacterium tuberculosis bacteria are inhaled and infect macrophages in the deep airways. For transmission to succeed, the bacteria must cope with environmental stress and remain viable and infectious in open air long enough for it to be inhaled and colonize macrophages. It is proposed that the success of highly-transmissible community isolates of M. tuberculosis is linked in part to their ability to endure the stress of aerosol residency.

Using laboratory strains and community isolates with epidemiological record of transmission success, we are investigating if aerosol residency under specific environmental conditions causes bacteria to die, reducing in turn its ability to colonize macrophages. We are also investigating if aerosol residency triggers differential gene expression in the bacteria, and if successful community isolates perform better than laboratory strains in aerosol tests.

We have set up a specialized platform in BSL3 to address these important knowledge gaps in TB transmission. This platform and its trained personnel also support Swedish pandemic laboratory preparedness with capabilities to study the aerobiology of new and emerging pathogens.

Results from this research will inform on environmental conditions that mitigate transmission of airborne M. tuberculosis, explain if the epidemiological success of highly-transmissible isolates is linked to their aerosol endurance, and provide novel insights on mycobacteria-macrophages interactions.

två bilder som visar provkammare.
Test chamber for aerosol experiments in Biosafety Level 3. Photo: Antonio Rothfuchs
THOR electrostatic air sampler.
THOR electrostatic air sampler. The device discharges ionization from the red ports causing ionized, airborne microbes to precipitate onto the collector rod on the center of the unit, which is removed for downstream analysis. Photo: Nuno Rufino de Sousa.

Detection of M. tuberculosis in cough aerosols

Aerosols carrying M. tuberculosis are released during coughing by persons with active TB in the lungs. Detection of M. tuberculosis in aerosols can help break the chain of transmission by identifying infectious persons and community hotspots of transmission. Tools that are easy-to-use and scalable in low-income, high-burden countries are however lacking.

With this in mind we have developed a small, low-cost electrostatic air sampler that can be used together with nucleic acid amplification tests to detect M. tuberculosis in aerosols. With collaborators at Stellenbosch University, South Africa, we are investigating the performance of the device at collecting aerosolized M. tuberculosis from the cough of TB patients. We are also investigating detection on our sampler against validated readouts for TB infectioussness in patients.

Results from this research will inform on the detection of M. tuberculosis in cough as a novel diagnostic approach or as an estimate of transmission risk. 

Our air sampler is also being used in the context of respiratory viruses. It has suceesfully been used to demonstrate infectious SARS-CoV-2 in cough and room air from hospitalized COVID-19 patients. We are currently investigating the use of our air sampler to detect an array of respiratory viruses in the indoor air of elderly homes in Sweden.

Support our research

Publications

Selected publications

Funding

Research Funding

Our research has received funding from various sources over the years. We acknowledge the generous support from the following bodies that have funded research in the group or enabled researchers to come and work with us:

  • Bill and Melinda Gates Foundation, USA
  • CAPES, Brazil
  • China Scholarship Council CSC
  • European Research Council
  • Karolinska Institutet
  • Karolinska Innovations AB
  • SciLifeLab
  • STINT
  • Swedish Heart-Lung Foundation
  • Swedish Research Council VR
  • Swedish Society for Medicine
  • Åke Wiberg Stiftelse

Collaboration with companies

In addition to academic collaborations we also work with companies and research institutes in different projects related to tuberculosis, aerobiology or infection control. Some of our current and previous private sector partnerships include:

  • Cepheid, USA
  • Semair Diagnostics, Sweden
  • Sarepta Therapeutics, USA
  • S3I, USA
  • Zeteo Tech, USA

Staff and contact

Group leader

All members of the group

Other people connected to the group

  • Achar, Jay

Former group members

  • Murilo Saturnino de Lima, visiting PhD student from ICC/Fiocruz, Brazil, 2024-2025.
  • Lei Shen, postdoc, 2017-2019. Now Shanghai Pulmonary Hospital, China.
  • Juliana Aggio, visiting PhD student from ICC/Fiocruz, Brazil, 2018-2019. Now postdoc Cambridge University, UK.
  • Pryscilla Wowk, postdoc/visiting researcher from ICC/Fiocruz, Brazil, 2017-2018.
  • Niklas Sandström, postdoc, 2015-2017. Now FOI, Sweden.
  • Vishnu Priya Bollampalli, PhD student. Defended in 2017. Now Cepheid, Stockholm.
  • Jintao Guo, postdoc, 2016-2017. Now ALK, Nanjing, China.
  • Sara Fernández León, research assistant, 2016-2017. Now Annoca, Södertälje.
  • Livia Yamashiro, visiting PhD student from UFSC Brazil, 2014. Now Arcus Biosciences, USA.

Contact and visit us

Contact information for the Antonio Rothfuchs research group at the Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet.

Postal address

Karolinska Institutet
Department of Microbiology, Tumor and Cell Biology
171 77 Stockholm

Visiting address (visitors, couriers, etc.)

Karolinska Institutet
Biomedicum, C9
Solnavägen 9
171 65 Solna

Delivery address (goods, parcels, etc.)

Tomtebodavägen 16
171 65 Solna

Where to find us

News archive

News from the research group